Date |
Title |
|
IMMUNOMEDICS AWARDED PATENTS FOR ANTIBODY FOR PEGYLATION AND PRETARGETING CONSTRUCTS |
|
IMMUNOMEDICS TO PARTICIPATE IN UPCOMING CONFERENCES |
|
IMMUNOMEDICS AWARDED PATENT FOR ANTIBODY THERAPY |
|
IMMUNOMEDICS APPOINTS KENNETH J ZUERBLIS TO BOARD OF DIRECTORS |
|
IMMUNOMEDICS ANNOUNCES SECOND QUARTER FISCAL 2010 RESULTS AND CLINICAL PROGRAM DEVELOPMENTS |
|
NEW TARGETED THERAPY FOR PANCREATIC CANCER PRESENTED AT CANCER CONFERENCE |
|
NEW BLOOD TEST FOR DETECTING EARLY STAGE PANCREATIC CANCER PRESENTED AT CANCER CONFERENCE |
|
IMMUNOMEDICS RECEIVES first MILESTONE PAYMENT FROM NYCOMED |
|
POTENTIAL LUPUS DRUG GAINS US PATENT |
|
IMMUNOMEDICS TO PRESENT AT 28th ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE |
